BeyondSpring Inc. Deferred Tax Assets, Goodwill and Intangible Assets
BeyondSpring Inc. (BYSI) had Deferred Tax Assets, Goodwill and Intangible Assets of $69.00 thousand as of 2019-12-31, per its 20-F filed 2021-04-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2021-04-30
- 2019-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $69.00K.
- 2018-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $191.00K.
- 2017-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $329.00K.
- 2016-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $428.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2019-12-31 | $69.00K 20-F · filed 2021-04-30 |
| 2018-12-31 | $191.00K 20-F · filed 2020-04-30 |
| 2017-12-31 | $329.00K 20-F · filed 2019-04-30 |
| 2016-12-31 | $428.00K 20-F · filed 2018-04-03 |
| 2015-12-31 | $586.00K 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |